Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection into masticatory and pharyngeal muscles for obstructive sleep apnea
RBR-9pr8j3xRecruiting
- Sponsor
- Hospital Universitário Gaffrée e Guinle
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of neuronox in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Hospital Universitário Gaffrée e Guinle. Started May 2023; status: recruiting.
02
Drugs
neuronox
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on RBR-9pr8j3x.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9pr8j3x.